Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

NCT06548282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-04

No results posted yet for this study

Summary

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Conditions

  • Psychological Distress
  • Type D Personality
  • Medication Adherence
  • Quality of Life

Interventions

OTHER

Acceptance and commitment therapy

Introduction: Build rapport and complete pre-assessment questionnaires. First Session: Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework. Second Session: Review feedback and encourage change. Assign homework. Third Session: Discuss acceptance and coping strategies. Assign homework. Fourth Session: Discuss cognitive diffusion and unhelpful thoughts. Assign homework. Fifth Session: Explore self-concept and mindfulness. Assign homework. Sixth Session: Identify and elaborate on values. Assign homework. Seventh Session: Discuss values, goals, and barriers. Assign homework. Eighth Session: Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Sponsors & Collaborators

  • Fatima Jinnah Women University

    lead OTHER

Principal Investigators

  • Sehrish Khan, PhD Scholar · Fatima Jinnah women University, Rawalpindi, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-21
Primary Completion
2024-09-21
Completion
2024-09-21

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06548282 on ClinicalTrials.gov